1. Home
  2. SIEB vs ELTX Comparison

SIEB vs ELTX Comparison

Compare SIEB & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Siebert Financial Corp.

SIEB

Siebert Financial Corp.

HOLD

Current Price

$2.13

Market Cap

68.4M

Sector

Finance

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

SELL

Current Price

$1.75

Market Cap

63.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SIEB
ELTX
Founded
1886
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.4M
63.3M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
SIEB
ELTX
Price
$2.13
$1.75
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $13.67
AVG Volume (30 Days)
30.1K
★ 292.6K
Earning Date
11-11-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.29
EPS
★ N/A
N/A
Revenue
★ $94,202,000.00
$2,301,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 12.28
N/A
52 Week Low
$1.53
$1.71
52 Week High
$4.14
$16.00

Technical Indicators

Market Signals
Indicator
SIEB
ELTX
Relative Strength Index (RSI) 44.75 29.35
Support Level $2.00 $1.74
Resistance Level $2.30 $1.97
Average True Range (ATR) 0.10 0.12
MACD -0.02 0.04
Stochastic Oscillator 8.00 5.77

Price Performance

Historical Comparison
SIEB
ELTX

About SIEB Siebert Financial Corp.

Siebert Financial Corp is a diversified financial services firm engaged in providing brokerage and financial advisory services. The coperates through two segments: Financial Services and Media, Sports and Entertainment. The Financial Services segment mainly operates as a securities broker-dealer and provides brokerage, custody, and clearing services for retail accounts, as well as insurance and advisory services, principal and proprietary trading, market making, securities lending, and investment banking and capital markets services. The Media, Sports and Entertainment segment is engaged in the production and distribution of music and media content, as well as talent management and sports representation. It generates the majority of its revenue from the Financial Services segment.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: